BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Nebraska
National Institutes of Health Clinical Center (CC)
Teva Branded Pharmaceutical Products R&D, Inc.
Canadian Cancer Trials Group
Cellerant Therapeutics
EVIVE Biotechnology
Biocad
Biocad
Sandoz
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen
Amgen
Amgen